Gecko Biomedical

Tissium, formerly known as Gecko Biomedical, is a medical device company based in Paris, France. Founded in 2013, Tissium specializes in the development and commercialization of biodegradable surgical adhesives and sealants aimed at tissue reconstruction. The company focuses on minimally invasive surgery and utilizes a proprietary biopolymers platform that features unique properties such as high viscosity and fast curing, allowing for precise local delivery during surgical procedures. Tissium's flagship product, GB-02, is designed for cardiovascular reconstruction but can be customized for various tissue repair applications, including guided tissue repair and localized drug delivery. The company also offers light-activated adhesive films and patches that enhance wound closure safety and efficiency. Tissium's technology is modular, integrating proprietary polymers, activation technologies, and delivery devices to support innovation across multiple therapeutic areas. The company collaborates with leading bioengineering experts and institutions to advance its next-generation tissue adhesives.

• Employees 3
• Founded 2013
• Total Funding $79155927